Ameriprise’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62,974
| Closed | -$78.1K | – | 3855 |
|
|
2024
Q1 | $78.1K | Sell |
62,974
-1,786
| -3% | -$2.22K | ﹤0.01% | 3795 |
|
|
2023
Q4 | $68K | Sell |
64,760
-12,755
| -16% | -$13.4K | ﹤0.01% | 3843 |
|
|
2023
Q3 | $531K | Buy |
77,515
+1,278
| +2% | +$8.75K | ﹤0.01% | 3391 |
|
|
2023
Q2 | $791K | Buy |
76,237
+4,372
| +6% | +$45.3K | ﹤0.01% | 3271 |
|
|
2023
Q1 | $581K | Sell |
71,865
-565
| -0.8% | -$4.57K | ﹤0.01% | 3364 |
|
|
2022
Q4 | $1.14M | Sell |
72,430
-845
| -1% | -$13.3K | ﹤0.01% | 3066 |
|
|
2022
Q3 | $1.15M | Sell |
73,275
-2,047
| -3% | -$32.2K | ﹤0.01% | 3052 |
|
|
2022
Q2 | $1.05M | Sell |
75,322
-730
| -1% | -$10.2K | ﹤0.01% | 3101 |
|
|
2022
Q1 | $1.31M | Buy |
76,052
+1,794
| +2% | +$30.9K | ﹤0.01% | 3089 |
|
|
2021
Q4 | $1.08M | Buy |
+74,258
| New | +$1.08M | ﹤0.01% | 3222 |
|
|
2017
Q2 | – | Sell |
-44,887
| Closed | -$1.34M | – | 3707 |
|
|
2017
Q1 | $1.34M | Sell |
44,887
-3,259
| -7% | -$97.2K | ﹤0.01% | 2744 |
|
|
2016
Q4 | $1.31M | Buy |
+48,146
| New | +$1.31M | ﹤0.01% | 2839 |
|